MMIRF (MedMira) Cyclically Adjusted PB Ratio: (As of Jul. 11, 2026)


What is MedMira Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


MedMira  (OTCPK:MMIRF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


MedMira Cyclically Adjusted PB Ratio Related Terms


MedMira Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for MedMira's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedMira Cyclically Adjusted PB Ratio Chart

MedMira Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MedMira Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MMIRF vs VRTX, REGN, ALNY: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, MedMira's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedMira Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MedMira's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where MedMira's Cyclically Adjusted PB Ratio falls into.



MedMira Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

MedMira's Cyclically Adjusted Book per Share for the quarter that ended in Apr. 2026 is calculated as:

For example, MedMira's adjusted Book Value per Share data for the three months ended in Apr. 2026 was:

Adj_Book=Book Value per Share/CPI of Apr. 2026 (Change)*Current CPI (Apr. 2026)
=-0.025/132.7364*132.7364
=-0.025

Current CPI (Apr. 2026) = 132.7364.

MedMira Quarterly Data

Book Value per Share CPI Adj_Book
201607 -0.009 101.844 -0.012
201610 -0.009 102.002 -0.012
201701 -0.009 102.318 -0.012
201704 -0.010 103.029 -0.013
201707 -0.011 103.029 -0.014
201710 -0.012 103.424 -0.015
201801 -0.013 104.056 -0.017
201804 -0.013 105.320 -0.016
201807 -0.013 106.110 -0.016
201810 -0.014 105.952 -0.018
201901 -0.014 105.557 -0.018
201904 -0.015 107.453 -0.019
201907 -0.016 108.243 -0.020
201910 -0.016 107.927 -0.020
202001 -0.017 108.085 -0.021
202004 -0.017 107.216 -0.021
202007 -0.018 108.401 -0.022
202010 -0.017 108.638 -0.021
202101 -0.018 109.192 -0.022
202104 -0.019 110.851 -0.023
202107 -0.019 112.431 -0.022
202110 -0.020 113.695 -0.023
202201 -0.013 114.801 -0.015
202204 -0.014 118.357 -0.016
202207 -0.014 120.964 -0.015
202210 -0.014 121.517 -0.015
202301 -0.014 121.596 -0.015
202304 -0.015 123.571 -0.016
202307 -0.016 124.914 -0.017
202310 -0.017 125.310 -0.018
202401 -0.017 125.072 -0.018
202404 -0.018 126.890 -0.019
202407 -0.019 128.075 -0.020
202410 -0.020 127.838 -0.021
202501 -0.020 127.443 -0.021
202504 -0.022 129.102 -0.023
202507 -0.023 130.290 -0.023
202510 -0.024 130.603 -0.024
202601 -0.025 130.366 -0.025
202604 -0.025 132.736 -0.025

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


MedMira Business Description

Other Exchanges MIR:Canada
Address 155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3
MedMira Inc is a biotechnology company engaged in the research, development, and manufacturing of rapid diagnostics and technologies. The company operates in one reportable operating segment, rapid diagnostic products and services. Its product line includes HIV, COVID-19, syphilis, Multiplex, Miriad RVF Toolkit, and H. pylori. The company generates revenue from North America, Europe, and other regions, with the majority generated from North America.